Ron Andrews, CEO of Clarient talks about the launch of GE’s cancer patient advocacy campaign and how molecular pathology advances are being used to develop new cancer treatments.
Ron Andrews Answers the Question “Is My Cancer Different?”
September 20th, 2011 · No Comments · Knowledge, News, Opinion
Tags:
No Comments so far ↓
There are no comments yet...Kick things off by filling out the form below.